Why Amazon Could be More Interested in Medical Devices Than Drugs
Amazon, as most everyone knows, has its fingers in a lot of pies. Source: BioSpace
The Complicated Relationship Between Celgene and President Trump
On multiple occasions, President Donald Trump has aimed his ire at pharma companies. Source: BioSpace
Fosun Pharma to Buy France's Tridem for $73M
Fosun Pharma said it would buy Tridem Pharma S.A.S. for $73M, in a move to expand its market share in Europe and Africa. Source: BioSpace
AstraZeneca Continues to Divest Assets, Takes Stake in Mereo BioPharma With New Deal
Astra signed a licensing deal with Mereo BioPharma to out license the oral inhibitor of neutrophil elastase to the smaller Mereo. Source: BioSpace
Judge Throws Out Claims of Anticompetitive Behavior Against Suboxone Maker
A federal judge dismissed more than 40 states’ claims against the parent company that manufactures Suboxone in a suit accusing it of suppressing generics. Source: Drug Industry Daily
EMA’s PRAC Recommends Additional Zinbryta Restrictions
The European Medicines Agency’s pharmacovigilance committee recommended additional restrictions on Biogen’s Zinbryta (daclizumab), after reviewing its effects on the liver. Source: Drug Industry Daily
Mylan Claims Another Victory Over Teva on Copaxone Patents
A UK court ruled for Mylan in its challenge to Teva’s patents on the long-acting version of Teva’s blockbuster multiple sclerosis drug. Source: Drug Industry Daily
Teva Sues Eli Lilly for Patent Infringement Over Migraine Drug
Teva Pharmaceutical Industries accused Eli Lilly of infringing on patents for its migraine drug in a lawsuit filed Oct. 24. Source: Drug Industry Daily
FDA Issues Guidance on GDUFA II Fee Payments and Consequences
The FDA published a draft guidance explaining the new GDUFA fee structure and the types of fees that took effect Oct. 1. The draft also covers how to submit payments…
- Go to the previous page
- 1
- …
- 275
- 276
- 277
- 278
- 279
- 280
- 281
- …
- 610
- Go to the next page